Search - tctmd.com

Displaying 241 - 260 of 372

Sort: Relevancy | Date

Presentation TCT 2017

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Presenter: Vinayak Bapat, Maurice Buchbinder, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Neil E. Moat

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

TCT 63: A Novel Patent Hemostasis Protocol - Prevention of Pseudoaneurysm After Transpedal Arterial Access for Evaluation and Treatment of Peripheral Arterial Disease

Presenter: Mark C. Bates, Dharam J. Kumbhani, Apurva Patel, MD

October 31, 2017

Presentation TCT 2017

High-Risk AF Patients: Changing the Emphasis From Stroke Prevention to Stroke and Hemorrhagic Complication Avoidance

Presenter: Christopher B. Granger, Horst Sievert, Michael D. Ezekowitz

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Presentation TCT 2017

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Presenter: David Hildick-Smith, Lars Sondergaard, Robert A. Byrne

October 29, 2017

Presentation TCT 2017

PFO Closure in Cryptogenic Stroke

Presenter: David Hildick-Smith, Lars Sondergaard

October 29, 2017

Presentation TCT 2016

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David Hildick-Smith

November 02, 2016

Presentation TCT 2016

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr.

November 02, 2016

Presentation TCT 2016

Global Hearts Action Plan for 2017

Presenter: Jack C. Lewin, Hugh J. Linnehan, Mpiko Ntsekhe

November 01, 2016

Presentation TCT 2016

Needs Assessment for Cath Lab Improvement and Support

Presenter: Jack C. Lewin, Hugh J. Linnehan, Graham A. Cassel

November 01, 2016

Presentation TCT 2016

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results

Presenter: Jack C. Lewin, Hugh J. Linnehan, Habib Gamra

November 01, 2016

Presentation TCT 2016

Update on Epidemiology, Prevention, Screening, and Control

Presenter: Habib Gamra, Ahmed Suliman, Bernard J. Gersh

November 01, 2016

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Optimizing Fluid Administration for Contrast Nephropathy Prevention

Presenter: Somjot S. Brar, Richard Solomon

November 01, 2016

Presentation TCT 2016

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda

November 01, 2016

Advertisement

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

TCT 63: A Novel Patent Hemostasis Protocol - Prevention of Pseudoaneurysm After Transpedal Arterial Access for Evaluation and Treatment of Peripheral Arterial Disease

High-Risk AF Patients: Changing the Emphasis From Stroke Prevention to Stroke and Hemorrhagic Complication Avoidance

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Cerebral Protection During TAVR: Routine vs Selective Use

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

PFO Closure in Cryptogenic Stroke

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Global Hearts Action Plan for 2017

Needs Assessment for Cath Lab Improvement and Support

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results

Update on Epidemiology, Prevention, Screening, and Control

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Optimizing Fluid Administration for Contrast Nephropathy Prevention

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content